Sales and Marketing

Showing 15 posts of 11520 posts found.

COVID-19 self-isolation cut to five full days in England

January 17, 2022 Sales and Marketing

The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …

Trial finds new CAR T-cell therapy is effective at killing cancer cells

January 10, 2022 Sales and Marketing

A Phase I clinical trial funded by the NIHR Invention for Innovation (i4i) programme, and supported by the NIHR UCLH …

European Commission approves Lumykras for lung cancer patients

January 10, 2022 Sales and Marketing

The European Commission (EC) has granted conditional marketing authorisation for Lyumykras (sotorasib), a first-in-class KRAS inhibitor, for the treatment of …

FDA approval of QUVIVIQ (daridorexant) for the treatment of insomnia

January 10, 2022 Sales and Marketing

Idorsia Ltd has announced the FDA approval of QUVIVIQâ„¢ (daridorexant) 25 mg and 50 mg for the treatment of adult …

Phase III trial into lebrikizumab shows positive results for atopic dermatitis patients

January 10, 2022 Sales and Marketing

Almirall has reported positive results from their Phase III trial into lebrikizumab, which demonstrated significant improvement and itch relief when …

Positive CHMP opinion for sickle cell disease anaemia tablet

December 20, 2021 Sales and Marketing

Global Blood Therapeutics (GBT) have announced the CHMP adopted a positive opinion recommending marketing authorisation for Oxbryta®  (vocelotor) tablets. Oxbryta …

FDA approval of Tezspire for severe asthma

December 20, 2021 Sales and Marketing

Tezpire (tezepelumab-ekko), manufactured by AstraZeneca and Amgen, has been approved in the US for the add-on maintenance treatment of adult …

Study reveals potential link between COVID-19 and Parkinson’s Disease

December 20, 2021 Sales and Marketing

Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …

New COVID-19 drug Sotrovimab becomes available on NHS

December 20, 2021 Sales and Marketing

Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
credit_-_crevis_shutterstock_340710245_720

CAR-T therapy trials show promise for earlier use in lymphoma

December 13, 2021 Sales and Marketing

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …

New clinical trial testing diabetes drug for reducing risk of Alzheimer’s

December 13, 2021 Sales and Marketing

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

UK government sets new booster target

December 13, 2021 Sales and Marketing

The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …

Feedback receives funding for cloud-based tuberculosis programme

December 13, 2021 Sales and Marketing

Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …

Maintaining product authenticity: The solution to a serial problem

December 6, 2021 Sales and Marketing

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …
The Gateway to Local Adoption Series

Latest content